Jubilant Ingrevia Limited (BOM:543271)

India flag India · Delayed Price · Currency is INR
641.75
-12.35 (-1.89%)
At close: Apr 30, 2025
Market Cap 101.50B
Revenue (ttm) 42.01B
Net Income (ttm) 2.06B
Shares Out n/a
EPS (ttm) 13.05
PE Ratio 49.19
Forward PE n/a
Dividend 5.00 (0.78%)
Ex-Dividend Date Feb 3, 2025
Volume 10,028
Average Volume 18,281
Open 662.95
Previous Close 654.10
Day's Range 635.55 - 662.95
52-Week Range 461.70 - 884.95
Beta n/a
RSI 44.50
Earnings Date May 13, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal... [Read more]

Industry Chemicals and Allied Products
Founded 2019
Employees 2,283
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543271
Full Company Profile

Financial Performance

In 2023, Jubilant Ingrevia's revenue was 41.36 billion, a decrease of -13.34% compared to the previous year's 47.73 billion. Earnings were 1.83 billion, a decrease of -40.52%.

Financial Statements

News

There is no news available yet.